OATP8 Activators are a class of chemical compounds designed to modulate the activity of the organic anion-transporting polypeptide 8 (OATP8), also known as solute carrier organic anion transporter 1B3 (SLCO1B3). OATP8 is a membrane-bound transporter protein primarily expressed in the liver, but also found in other tissues such as the intestine and kidney. This transporter plays a pivotal role in the uptake and transport of a wide range of endogenous and exogenous substances, including bile acids, hormones, drugs, and xenobiotics, across cellular membranes. OATP8 Activators are synthesized with the intent of selectively interacting with OATP8, enhancing or inhibiting its transport functions, although the specific mechanisms can vary among different compounds within this chemical class.
The activation or modulation of OATP8 by these compounds can influence the cellular uptake, distribution, and disposition of various molecules, affecting their pharmacokinetics and overall bioavailability. OATP8 is particularly relevant for the transport of bile acids in the liver, which is essential for bile acid homeostasis and the enterohepatic circulation. Additionally, OATP8 is involved in the hepatic uptake of many drugs, making it a crucial determinant of drug metabolism and elimination. By targeting OATP8, these activators enhance or inhibit the transport of specific substrates, impacting their absorption, distribution, and elimination. Consequently, OATP8 Activators serve as valuable tools in pharmacology and drug development research, allowing scientists to investigate the role of OATP8 in drug disposition, bile acid transport, and xenobiotic metabolism. However, it's essential to note that the specific mechanisms and outcomes of OATP8 activation or inhibition may vary depending on the context, the particular substrate, and the compound used within this chemical class, as OATP8 is involved in the transport of diverse molecules with distinct physicochemical properties.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Omeprazole | 73590-58-6 | sc-202265 | 50 mg | $67.00 | 4 | |
Omeprazole, a proton pump inhibitor, potentially increases OATP1B3 expression through mechanisms involving liver enzyme modulation, influencing drug transport. | ||||||
Gemfibrozil | 25812-30-0 | sc-204764 sc-204764A | 5 g 25 g | $66.00 $267.00 | 2 | |
Gemfibrozil, a lipid-regulating agent, may enhance OATP1B3 expression by modulating liver enzymes and transporters involved in lipid and drug metabolism. | ||||||
Efavirenz | 154598-52-4 | sc-207612 | 10 mg | $171.00 | 3 | |
Efavirenz can potentially upregulate OATP1B3 expression through mechanisms involving the modulation of liver enzymes and drug transporters. | ||||||
Troglitazone | 97322-87-7 | sc-200904 sc-200904B sc-200904A | 5 mg 10 mg 25 mg | $110.00 $204.00 $435.00 | 9 | |
Troglitazone potentially increases OATP1B3 expression by activating peroxisome proliferator-activated receptors, influencing liver metabolism. | ||||||
Nelfinavir | 159989-64-7 | sc-507314 | 10 mg | $168.00 | ||
Nelfinavir, an antiretroviral agent, may enhance OATP1B3 expression through its effects on liver enzymes and transporters involved in drug metabolism. | ||||||
Clofibrate | 637-07-0 | sc-200721 | 1 g | $33.00 | ||
Clofibrate, a lipid-lowering agent, potentially induces OATP1B3 expression by modulating the activity of enzymes and transporters involved in lipid and drug metabolism. | ||||||